| PDF (565kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-48188
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.4818
Alternative Links zum Volltext:Pubmed
Zusammenfassung
The diastereoisomeric dichloro-[1-(2-, 3- and 4-hydroxyphenyl)-2-phenylethylenediamine]platinum(II) complexes were tested on two human ovarian cancer cell lines NIH: OVCAR-3 and SK-OV-3, both resistant against cisplatin. Dichloro-[threo-1-(3-hydroxyphenyl)-2-phenylethylenediamine]platinum(II) (threo-5-PtCl2) proved to be the most active representative of the new series, producing cytocidal ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik